March 8th
2008
3:20 AM
Even more information regarding subcutaneous atrophy and the class of drugs which Kenalog fall in to:
"Subcutaneous atrophy developed in a 36-year-old woman at the site of a triamcinolone acetonide (Kenalog) injection for subdeltoid bursitis. Occurrence of local atrophy after corticosteroid injection is relatively frequent yet unappreciated. It is more common in young women and girls who are given preparations with a lesser degree of water solubility. Although the condition is often reversible, instances of long-term disfigurement are well documented. This complication of a useful treatment method can be avoided by following a set of precautions for local injection of corticosteroids."
The above excerpt from a 1986 article in the U.S National Library of Medicine. There is also an article as far back as 1967 in the British Medical Journal (10/14/1967) that puts forward the same theory (though it is argued about in the editorial of the Journal).
Anyone who has experienced this problem should print this out and show it to their doctors. Presumably and hopefully your doctor is aware of medical journals and respects the DATA!
-- By wikd1 | Reply | (1) replies | Private Message me
February 4th
2009
8:56 AM
My daughter was on Yasmin for a year, and almost immediately began experiencing a variety of symptoms including depression, mood swings, headaches, nausea, tingling and numbness in her legs, etc. Doctors checked her thyroid, gave her a cat scan, prescribed anti-depressants, anti-anxiety, anti-psychotic drugs ( she started hearing voices) and warned that she couldn't stop these drugs abruptly without causing their own serious side effects. After her second hospitalization for suicidal threats, the psychiatrist, at our insistence took her off Yasmin, the only prescription drug that she was taking when the problems began. She began to feel normal within a few months, and was able to wean herself off Prozac a short time later. We are convinced that this is a very dangerous drug.
-- By veryconcerned | Reply | Private Message meIn doing research, I found that there is a consumer watchdog group, called Public Citizen ( ******), which monitors FDA reports and has successfully lobbied to have a number of drugs removed from the market. They have Yasmin listed on their "do not use" list ( ******) because of the risk of increased potassium levels and blood clots. The British Medical Journal (******) also has articles suggesting a link between Yasmin and thromboembolisms.
I believe the first step for any of us who have had adverse experiences with this drug is to go to FDA.gov and "Report a Problem". My understanding is that the level of severity of the problem leads to a required response on the part of the agency.
I think the biggest problem is that this drug is very widely prescribed but that few doctors seem informed enough to make a connection when the serious side effects ( fully described on the label) begin to emerge.